At present she is working as Medical Assistant in the Department of Nephrology and Dialysis, Sant’Anna Hospital, ASST Lariana, Como, Italy, which is directed by Dott GianVincenzo Melfa. Here, she works in the Nephrology Ward, in limited-assistance dialysis center and follows patients affected by primary and secondary glomerulonephritis and atypical haemolytic uremic syndrome.
She has collaborated in several clinical trials and received the training for the Good Clinical Practices.
She has many scientific interests, including RAS inhibition and its role in slowing the progression of chronic nephropathies, anaemia and its therapy (iron, ESA, HIF-PHD inhibitors), cardiovascular risk in CKD, nutrition in CKD patients, the genetics and treatment of primary and secondary glomerulonephritis, oxidative stress in CKD, SGLT2 inhibitors.
She has co-authored the position paper of ERBP on anaemia treatment in 2013 and wrote scientific papers on anaemia treatments and HIF stabilisers.
She had been Member of ERBP group of ERA-EDTA and she is part of the Steering Committee of the Working Group EURECA-m of ERA-EDTA.
She is reviewer for many scientific journals. She is member of the Editorial Board of the Journal of Nephrology and of the Journal of Clinical Medicine. She is sub-editor of Nephrology Dialysis Transplantation for chronic kidney disease
At the moment she has contributed to nearly 240 publications on scientific journals.
At present she is working as Medical Assistant in the Department of Nephrology and Dialysis, Sant’Anna Hospital, ASST Lariana, Como, Italy, which is directed by Dott GianVincenzo Melfa. Here, she works in the Nephrology Ward, in limited-assistance dialysis center and follows patients affected by primary and secondary glomerulonephritis and atypical haemolytic uremic syndrome.
She has collaborated in several clinical trials and received the training for the Good Clinical Practices.
She has many scientific interests, including RAS inhibition and its role in slowing the progression of chronic nephropathies, anaemia and its therapy (iron, ESA, HIF-PHD inhibitors), cardiovascular risk in CKD, nutrition in CKD patients, the genetics and treatment of primary and secondary glomerulonephritis, oxidative stress in CKD, SGLT2 inhibitors.
She has co-authored the position paper of ERBP on anaemia treatment in 2013 and wrote scientific papers on anaemia treatments and HIF stabilisers.
She had been Member of ERBP group of ERA-EDTA and she is part of the Steering Committee of the Working Group EURECA-m of ERA-EDTA.
She is reviewer for many scientific journals. She is member of the Editorial Board of the Journal of Nephrology and of the Journal of Clinical Medicine. She is sub-editor of Nephrology Dialysis Transplantation for chronic kidney disease
At the moment she has contributed to nearly 240 publications on scientific journals.